Gestational Diabetes Mellitus Prevalence, Screening, and Treatment Practices in American Samoa, 2016.

Autor:	Meyer BN; Center for Global and Immigrant Health, University of California Los Angeles Fielding School of Public Health, Los Angeles, CA., Cash HL; Regional Epidemiology Unit, Pacific Island Health Officers Association, Honolulu, HI., Uso A; Department of Maternal and Children's Health, American Samoa Department of Health, Pago Pago, American Samoa., Eliapo-Unutoa I; Department of Maternal and Children's Health, American Samoa Department of Health, Pago Pago, American Samoa., Ropeti R; Department of Maternal and Children's Health, American Samoa Department of Health, Pago Pago, American Samoa., Muasau-Howard B; OBGYN Department, Lyndon B. Johnson Tropical Medical Center, Pago Pago, American Samoa.
Jazyk:	angličtina
Zdroj:	Hawai'i journal of health & social welfare [Hawaii J Health Soc Welf] 2022 Jul; Vol. 81 (7), pp. 185-192.
Abstrakt:	Gestational diabetes mellitus (GDM) is a serious pregnancy complication and understudied public health issue in American Samoa. The goals of this study were to (1) estimate the prevalence of GDM in American Samoa, (2) evaluate current screening practices for GDM, and (3) evaluate obtainment of GDM treatments in 2016. This cross-sectional study used 3 data sources: electronic health records, a labor and delivery logbook, and the American Samoa Department of Health (ASDOH) Maternal and Children's Health (MCH) Postpartum database. Out of 995 women with a singleton birth in American Samoa during the study period, 60.1% (n=598) completed a glucose tolerance test for GDM. Of these women, 41.8% (n=250) completed the testing within the recommended 24-28 weeks gestation timeframe. The estimated prevalence of GDM was 14.0% (95% confidence interval: 11.2-16.8) but has many limitations due to missing data. There were 4 treatments analyzed: nutrition counseling, insulin, metformin, and diabetes counseling. Of all women diagnosed with GDM (n=84), 76% were prescribed any of the 4 treatments. However, only 52% of those women obtained the treatment prescribed. Access to testing and treatment needs to be expanded to provide adequate prenatal care to women in American Samoa. (©Copyright 2022 by University Health Partners of Hawai‘i (UHP Hawai‘i).)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu